3420 Central Expressway
408-731-5000 or 888-362-2947
After pioneering the microarray technology used to publish more than 20,000
scientific papers, Affymetrix is evolving into a provider of scalable,
innovative genomic analysis tools and reagents for discovery, exploration,
validation, and genetic testing. The acquisitions of Panomics and USB bring
high-throughput, multi- to single-gene assays and premium-value molecular
biology reagents to our customers, enabling a complete solution for
genome-wide analysis studies and a range of products for cellular and
protein analysis studies.
Researchers around the world use Affymetrix technologies to better understand
the role that genes play in disease, the effectiveness and safety of
therapies, and many other biological factors that affect human well-being.
Affymetrix microarray technology has been used to make groundbreaking
discoveries to help the scientific and medical communities investigate
conditions such as infertility, HIV, Parkinson's disease, diabetes, malaria,
cancer, and many others. Our mission is to revolutionize how the world
benefits from genetic information.
Affymetrix contributed significantly to the formation of today's genetic
analysis markets, and we will continue to drive the genomics revolution with
a single-minded vision: to help all individuals benefit from understanding
their own DNA.